Clinical Approach to Hematuria
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of hematuria
Hematuria is one of the most common urological presentations, affecting approximately 2.5% to 20% of the general adult population depending on age, sex, and screening method. Microscopic hematuria is found in up to 40% of patients during routine urinalysis, though the clinical significance varies widely. Importantly, hematuria may be the sole presenting sign of urological malignancy in 5% to 22% of cases, making thorough evaluation essential. In patients over 50 years of age with gross hematuria, the risk of underlying bladder cancer approaches 20% to 25%.
Definition
Hematuria is defined as the presence of blood in the urine. Gross hematuria (also called macroscopic or visible hematuria) is blood visible to the naked eye, while microscopic hematuria is defined as ≥3 red blood cells per high-power field on microscopic examination of urinary sediment from two of three properly collected specimens. Clinically significant microscopic hematuria requires confirmation on repeat testing to exclude transient causes.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Single episode or less than 2 weeks | Urinary tract infection, nephrolithiasis, trauma, vigorous exercise, menstrual contamination | Often self-limited; evaluate for infection and trauma first |
| Recurrent | Multiple episodes over weeks to months | Bladder or renal malignancy, immunoglobulin A nephropathy, benign prostatic hyperplasia, nephrolithiasis | Higher suspicion for malignancy; requires comprehensive urological workup |
| Persistent | Continuous over more than 3 months | Glomerulonephritis, chronic interstitial nephritis, polycystic kidney disease, malignancy | Suggests structural or glomerular pathology; nephrology referral often indicated |
Classification by Visibility
Gross Hematuria (Visible)
Blood visible to the naked eye, typically requiring more than 1 mL of blood per liter of urine. The urine may appear pink, red, brown, or tea-colored. Gross hematuria has a higher likelihood of significant pathology, with urological malignancy found in 10% to 20% of cases. Clots may indicate a lower urinary tract source. Always warrants urgent evaluation.
Microscopic Hematuria (Non-visible)
Detectable only on urinalysis (≥3 red blood cells per high-power field) or dipstick testing. May be asymptomatic and discovered incidentally. Transient microscopic hematuria is common and often benign, but persistent microscopic hematuria requires evaluation. Risk of malignancy is lower (2% to 5%) but not negligible, especially in high-risk patients.
Classification by Source
| Source | Characteristics | Red Blood Cell Morphology | Associated Findings |
|---|---|---|---|
| Glomerular | Brown or tea-colored urine; uniform bleeding throughout stream; usually painless | Dysmorphic red blood cells (more than 80%); acanthocytes present | Red blood cell casts, proteinuria (more than 500 mg per day), hypertension, edema, elevated creatinine |
| Non-glomerular (Upper Tract) | Red or pink urine; may have clots (often vermiform or worm-shaped); may have flank pain | Isomorphic (normal) red blood cells | Flank pain, hydronephrosis on imaging, history of stones |
| Non-glomerular (Lower Tract) | Bright red blood; clots common; may have dysuria or frequency | Isomorphic (normal) red blood cells | Dysuria, frequency, urgency, suprapubic pain, terminal hematuria |
Classification by Timing During Urination
| Pattern | Description | Suggests |
|---|---|---|
| Initial Hematuria | Blood at the beginning of the urinary stream, clearing toward the end | Urethral source (urethritis, urethral caruncle, urethral tumor, prostatic bleeding) |
| Terminal Hematuria | Blood appearing at the end of the urinary stream | Bladder neck or prostatic urethra source (bladder neck polyp, prostatic disease, trigone lesion) |
| Total Hematuria | Blood present throughout the entire urinary stream | Bladder or upper urinary tract source (kidney, ureter); most common pattern |
Key Concept: The Critical Distinction
The most important initial distinction is between glomerular and non-glomerular hematuria, as this determines the diagnostic pathway:
- Glomerular hematuria → Nephrology evaluation (serologies, possible renal biopsy)
- Non-glomerular hematuria → Urological evaluation (imaging, cystoscopy)
Look for dysmorphic red blood cells, red blood cell casts, and significant proteinuria to identify glomerular sources. Their absence suggests a urological cause requiring imaging and cystoscopy.
Pseudohematuria — Rule Out First
Not all red or brown urine is hematuria. Always confirm true hematuria with microscopic examination before extensive workup:
- Foods: Beets, blackberries, rhubarb
- Medications: Rifampin, phenazopyridine, nitrofurantoin, metronidazole
- Pigments: Myoglobin (rhabdomyolysis), hemoglobin (hemolysis)
- Porphyria: Porphobilinogen in urine
- Menstrual contamination: Common cause of false-positive
- Concentrated urine: May appear darker
Dipstick positive but no red blood cells on microscopy suggests hemoglobinuria or myoglobinuria rather than true hematuria.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of hematuria
Blood enters the urine when there is disruption of the normal barriers between the vascular system and the urinary collecting system. This can occur at any level from the glomerulus to the urethral meatus. Understanding the anatomy and mechanisms helps localize the source and guides the diagnostic approach. The character of the bleeding—including red blood cell morphology, presence of casts, and associated proteinuria—provides crucial clues to the site of origin.
Anatomical Sources of Hematuria
| Anatomical Level | Structures | Barrier to Blood | How Barrier Is Breached |
|---|---|---|---|
| Glomerulus | Glomerular capillaries, basement membrane, podocytes | Glomerular filtration barrier (endothelium, basement membrane, podocytes) | Immune-mediated inflammation, basement membrane defects, podocyte injury |
| Renal Tubules and Interstitium | Tubular epithelium, peritubular capillaries, interstitial tissue | Tubular basement membrane, intact epithelium | Infection, drug-induced injury, papillary necrosis, polycystic disease |
| Renal Pelvis and Ureter | Transitional epithelium (urothelium), submucosal vessels | Intact urothelial lining | Stones, tumors, infection, stricture, trauma |
| Bladder | Urothelium, detrusor muscle, submucosal vasculature | Intact urothelial lining | Infection, malignancy, radiation, stones, trauma |
| Prostate (Males) | Prostatic glands, prostatic urethra, periurethral vessels | Prostatic epithelium and capsule | Benign prostatic hyperplasia, prostatitis, prostatic carcinoma |
| Urethra | Urethral epithelium, periurethral glands, corpus spongiosum | Intact urethral mucosa | Infection, trauma, stricture, caruncle, tumor |
Understanding Glomerular Versus Non-Glomerular Bleeding
Glomerular Bleeding Mechanism
Why red blood cells become dysmorphic:
When red blood cells pass through damaged glomerular basement membrane, they undergo mechanical trauma and osmotic stress as they traverse the nephron. The cells are squeezed through small gaps in the basement membrane, then exposed to varying osmolality in the tubular fluid. This creates characteristic dysmorphic shapes including:
- Acanthocytes: Ring-shaped cells with membrane blebs (greater than 5% is highly specific for glomerular bleeding)
- Codocytes: Target-shaped cells
- Variable size and shape: Anisocytosis and poikilocytosis
Red blood cell casts form when cells become trapped in Tamm-Horsfall protein within the tubules—pathognomonic for glomerular disease.
Non-Glomerular Bleeding Mechanism
Why red blood cells remain isomorphic:
Blood entering the urinary tract below the glomerulus does not traverse the nephron. Red blood cells enter directly into the collecting system where they are not subjected to the mechanical and osmotic stresses of tubular passage. Therefore, they retain their normal biconcave disc shape:
- Uniform morphology: Normal biconcave discs
- Uniform size: 6 to 8 micrometers diameter
- May form clots: Especially from lower tract sources where blood is not diluted
Absence of red blood cell casts and minimal proteinuria (less than 500 mg per day) further supports a non-glomerular source.
How Specific Conditions Cause Hematuria
| Condition | Mechanism of Bleeding | Clinical Implication |
|---|---|---|
| Immunoglobulin A Nephropathy | Immunoglobulin A immune complex deposition in mesangium causes mesangial proliferation and glomerular basement membrane damage; episodes often triggered by mucosal infections | Classic “synpharyngitic” hematuria (occurs during or 1 to 2 days after upper respiratory infection, unlike post-streptococcal which occurs 1 to 2 weeks later) |
| Thin Basement Membrane Nephropathy | Inherited defect causing diffusely thinned glomerular basement membrane (less than 250 nanometers versus normal 300 to 400 nanometers); red blood cells can pass through more easily | Benign familial hematuria; usually isolated microscopic hematuria with excellent prognosis |
| Alport Syndrome | Mutations in type IV collagen genes cause progressive basement membrane thinning, splitting, and lamellation; leads to progressive glomerulosclerosis | Progressive renal failure, sensorineural hearing loss, ocular abnormalities; X-linked most common |
| Nephrolithiasis | Direct mucosal trauma from stone passage; stones cause abrasion, inflammation, and vascular injury to urothelium | Colicky flank pain with hematuria; 85% of patients with renal colic have hematuria |
| Urinary Tract Infection and Cystitis | Bacterial invasion causes mucosal inflammation, hyperemia, and capillary fragility; hemorrhagic cystitis involves diffuse bladder mucosal bleeding | Associated dysuria, frequency, urgency; hematuria resolves with treatment of infection |
| Bladder Cancer | Tumor neovascularization creates fragile, abnormal vessels prone to bleeding; tumor invasion disrupts normal urothelial barrier | Painless gross hematuria is the classic presentation; intermittent bleeding may delay diagnosis |
| Renal Cell Carcinoma | Highly vascular tumor invades renal parenchyma and collecting system; tumor necrosis and vascular invasion cause bleeding | Classic triad (hematuria, flank pain, palpable mass) present in only 10% of cases; often incidental finding |
| Benign Prostatic Hyperplasia | Enlarged periurethral glands compress prostatic urethra; increased vascularity at bladder neck; venous congestion leads to rupture of submucosal vessels | Usually microscopic hematuria; may have gross hematuria after straining or with concurrent anticoagulation |
| Exercise-Induced Hematuria | Multiple mechanisms: direct bladder trauma from repetitive impact (runner’s bladder), renal vasoconstriction with ischemic injury, increased glomerular permeability, myoglobinuria | Transient; resolves within 24 to 72 hours of rest; more common with high-intensity or long-duration exercise |
| Anticoagulation-Associated | Anticoagulants unmask underlying pathology rather than cause hematuria directly; bleeding from previously subclinical lesions | Important: Anticoagulation should prompt evaluation, not explain away hematuria; up to 25% have significant underlying pathology |
Often Overlooked Mechanism: Nutcracker Syndrome
The left renal vein passes between the aorta and superior mesenteric artery. In thin patients (especially young women), this space may narrow, compressing the left renal vein and causing venous hypertension. This leads to rupture of thin-walled varices in the renal pelvis and ureter, causing intermittent hematuria. Consider this in young patients with unexplained left-sided hematuria, especially if associated with left flank or pelvic pain, varicocele (males), or pelvic congestion symptoms (females). Doppler ultrasound or computed tomography angiography can demonstrate the compression.
Clinical Significance of Blood Clots
| Clot Characteristic | Likely Source | Explanation |
|---|---|---|
| No clots, brown or tea-colored urine | Glomerular | Blood is diluted through nephron; urokinase in tubular fluid lyses any forming clots |
| Thin, vermiform (worm-shaped) clots | Upper tract (ureter) | Clots form in the narrow ureter and take its shape as they pass |
| Large, irregular clots | Bladder | Blood pools in bladder and clots before voiding; may cause urinary retention |
| Small clots with initial hematuria | Urethra or prostate | Blood enters stream at beginning of voiding from distal source |
Systemic Factors Affecting Hematuria
Coagulation Status
Key point: Anticoagulants and antiplatelet agents do not cause hematuria but unmask underlying pathology.
Clinical relevance: Patients on warfarin, direct oral anticoagulants, or aspirin with new hematuria require full evaluation—malignancy is found in up to 25%.
Hydration Status
Key point: Concentrated urine may appear darker and have higher red blood cell concentration per high-power field.
Clinical relevance: Always note urine specific gravity; concentrated specimens may exaggerate findings.
Menstrual Status
Key point: Menstrual contamination is the most common cause of false-positive hematuria in premenopausal women.
Clinical relevance: Repeat urinalysis at mid-cycle; use clean-catch technique or consider catheterized specimen if needed.
3. History Taking
A comprehensive approach to eliciting the hematuria history
Red Flags — Require Urgent Evaluation
- Age over 40 with gross hematuria — High risk of urothelial malignancy
- Painless gross hematuria — Classic presentation of bladder cancer
- Significant weight loss — Suggests malignancy
- Heavy smoking history — Major risk factor for bladder cancer
- Occupational carcinogen exposure — Aniline dyes, aromatic amines, rubber industry
- Palpable abdominal or flank mass — Renal cell carcinoma until proven otherwise
- Urinary retention with clots — May require urgent catheterization and irrigation
- Hemodynamic instability — Significant blood loss requiring resuscitation
- Known bladder or kidney tumor — Recurrence or progression
- Recent urological procedure — Post-procedural hemorrhage
Systematic History: The “BLOOD” Approach
Use the mnemonic “BLOOD” to ensure comprehensive history taking for hematuria:
- B — Bleeding characteristics: Color (pink, red, brown, tea-colored)? Clots present? Timing during urination (initial, terminal, total)? Duration and frequency of episodes?
- L — Location clues and associated symptoms: Flank pain (upper tract)? Suprapubic pain (bladder)? Dysuria, frequency, urgency (infection)? Colicky pain (stones)?
- O — Onset and precipitants: Sudden or gradual? Triggered by exercise, trauma, sexual activity, or recent infection? Relationship to menstruation?
- O — Other medical history: Previous hematuria episodes? Known kidney disease, stones, or urological conditions? Recent procedures? Radiation history? Family history of kidney disease or malignancy?
- D — Drugs and exposures: Anticoagulants? Antiplatelet agents? Cyclophosphamide? NSAIDs? Smoking history? Occupational exposures? Dietary factors (beets, berries)?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Bladder cancer | Painless gross hematuria, age over 40, smoking history, intermittent episodes | “Have you ever smoked cigarettes? Have you worked with dyes, rubber, or chemicals? Is the bleeding painless?” |
| Urinary tract infection | Dysuria, frequency, urgency, suprapubic discomfort, fever | “Do you have burning with urination? Are you going to the bathroom more often? Do you feel like you need to rush to urinate?” |
| Nephrolithiasis | Severe colicky flank pain radiating to groin, nausea, restlessness | “Do you have severe pain in your side or back that comes in waves? Does the pain move toward your groin? Have you had kidney stones before?” |
| Glomerulonephritis | Brown or tea-colored urine, facial or peripheral edema, recent infection, hypertension | “Is your urine brown or tea-colored rather than red? Have you noticed swelling in your face or legs? Did you have a sore throat or skin infection recently?” |
| Immunoglobulin A nephropathy | Gross hematuria during or within 1 to 2 days of upper respiratory infection | “Did the blood in your urine start at the same time as your cold or sore throat? Does this happen every time you get sick?” |
| Benign prostatic hyperplasia | Older male, weak stream, hesitancy, nocturia, incomplete emptying | “Do you have difficulty starting urination? Is your stream weak? Do you wake up at night to urinate? Do you feel like your bladder doesn’t empty completely?” |
| Renal cell carcinoma | Flank pain, palpable mass, weight loss, paraneoplastic symptoms | “Have you had unexplained weight loss? Do you have a dull ache in your side? Have you noticed any lumps in your abdomen?” |
| Exercise-induced hematuria | Hematuria following strenuous exercise, resolves within 72 hours | “Did you do any vigorous exercise or running before you noticed the blood? Does it go away within a day or two of resting?” |
| Trauma | Recent injury, fall, motor vehicle accident, contact sports | “Have you had any recent injuries, falls, or accidents? Have you been hit in the back, side, or lower abdomen?” |
| Polycystic kidney disease | Family history, flank fullness, hypertension, liver cysts, intracranial aneurysms | “Does anyone in your family have kidney disease, especially cysts in the kidneys? Have you been told you have high blood pressure?” |
Medication and Substance History
Medications That Cause or Unmask Hematuria
- Anticoagulants (warfarin, direct oral anticoagulants) — Unmask underlying lesions; do not dismiss as “just anticoagulation”
- Antiplatelet agents (aspirin, clopidogrel) — Similar to anticoagulants; require full workup
- Cyclophosphamide — Causes hemorrhagic cystitis via acrolein metabolite
- Nonsteroidal anti-inflammatory drugs — Acute interstitial nephritis, papillary necrosis
- Penicillins and cephalosporins — Drug-induced interstitial nephritis
- Rifampin — Causes red-orange discoloration (pseudohematuria)
- Phenazopyridine — Orange discoloration (pseudohematuria)
Social and Occupational History
- Smoking: Single most important risk factor for bladder cancer; quantify pack-years; includes all tobacco forms
- Occupational exposures: Aniline dyes, aromatic amines (benzidine, beta-naphthylamine), rubber manufacturing, leather work, aluminum production, painting
- Travel history: Schistosoma haematobium endemic areas (Africa, Middle East) — causes squamous cell bladder cancer
- Sexual history: Recent sexual activity (urethral trauma, urinary tract infection); sexually transmitted infections (urethritis)
- Radiation history: Prior pelvic radiation causes radiation cystitis (may occur years later)
- Exercise: Recent strenuous exercise, marathon running, contact sports
- Diet: Beets, blackberries, rhubarb cause pseudohematuria
Family History Considerations
| Family History Finding | Consider | Follow-up Questions |
|---|---|---|
| Hematuria in multiple family members | Thin basement membrane nephropathy (benign familial hematuria), Alport syndrome | “Did any relatives have kidney failure or need dialysis? Did any have hearing problems at a young age?” |
| Polycystic kidney disease | Autosomal dominant polycystic kidney disease | “Did anyone in your family have large kidneys with cysts? Did anyone have brain aneurysms?” |
| Kidney or bladder cancer | Hereditary cancer syndromes (von Hippel-Lindau, Lynch syndrome) | “Has anyone in your family had kidney cancer, especially at a young age? Any other cancers in the family?” |
| Sickle cell disease or trait | Papillary necrosis, renal medullary carcinoma | “Does anyone in your family have sickle cell disease or carry the sickle cell trait?” |
Characterizing the Bleeding: Key Questions
- Color: Pink suggests mild bleeding; bright red suggests active, brisk bleeding; brown or tea-colored suggests glomerular source or old blood
- Clots: Presence of clots suggests non-glomerular source; worm-shaped clots suggest ureteral origin; large clots suggest bladder origin
- Timing: Initial (urethral), terminal (bladder neck or prostate), or total (bladder or above)
- Pain: Painful hematuria suggests infection, stones, or clot passage; painless hematuria raises concern for malignancy
- Intermittent versus continuous: Malignancy often causes intermittent hematuria, which may falsely reassure patients between episodes
4. Physical Examination
A systematic head-to-toe approach for hematuria
Systematic Framework: Use the “General to Genitourinary” approach for complete examination of patients presenting with hematuria. Remember that examination may be entirely normal in many cases, but specific findings can significantly narrow the differential diagnosis.
General Inspection
- Appearance: Pallor (anemia from chronic blood loss or renal failure), cachexia (malignancy), cushingoid features (paraneoplastic syndrome)
- Skin: Purpura or petechiae (vasculitis, coagulopathy), pallor (anemia), rashes (systemic lupus erythematosus, Henoch-Schönlein purpura), track marks (endocarditis risk)
- Edema: Periorbital or facial edema (nephritic syndrome), peripheral edema (nephrotic syndrome, heart failure, renal failure)
- Hydration status: Dry mucous membranes, decreased skin turgor (dehydration may concentrate urine)
- Level of distress: Writhing with pain (renal colic) versus comfortable (painless hematuria of malignancy)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Blood Pressure | Hypertension (greater than 140/90 mmHg), hypotension with tachycardia | Hypertension suggests glomerulonephritis, polycystic kidney disease, or renal parenchymal disease; hypotension may indicate significant hemorrhage |
| Heart Rate | Tachycardia (greater than 100 beats per minute) | May indicate pain, anxiety, hypovolemia from significant bleeding, or sepsis from urinary tract infection |
| Temperature | Fever (greater than 38°C or 100.4°F) | Suggests urinary tract infection, pyelonephritis, or post-obstructive infection; consider urosepsis if hemodynamically unstable |
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute) | May indicate pain, metabolic acidosis (uremia), pulmonary edema (fluid overload), or sepsis |
| Oxygen Saturation | Hypoxia (less than 94% on room air) | May indicate pulmonary edema from fluid overload, pulmonary embolism, or Goodpasture syndrome (pulmonary hemorrhage) |
Head, Eyes, Ears, Nose, and Throat Examination
Eyes
Conjunctival pallor: Anemia from chronic blood loss
Anterior lenticonus: Conical protrusion of lens — pathognomonic for Alport syndrome
Dot-and-fleck retinopathy: Also seen in Alport syndrome
Roth spots: Suggest endocarditis (embolic hematuria)
Hypertensive retinopathy: Indicates chronic hypertension, supports renal parenchymal disease
Ears, Nose, and Throat
Hearing assessment: Sensorineural hearing loss in Alport syndrome (high-frequency loss)
Pharyngitis: Recent streptococcal infection may precede post-infectious glomerulonephritis
Nasal septal perforation: Granulomatosis with polyangiitis (formerly Wegener granulomatosis)
Oral ulcers: Systemic lupus erythematosus
Cardiovascular Examination
- Jugular venous pressure: Elevated in fluid overload (nephritic syndrome, renal failure, heart failure)
- Heart sounds: New murmur may suggest endocarditis (embolic glomerulonephritis); pericardial friction rub in uremic pericarditis
- Peripheral pulses: Diminished pulses may suggest vasculitis or atheroembolic disease
- Peripheral edema: Bilateral pitting edema suggests nephrotic syndrome, renal failure, or heart failure
Respiratory Examination
- Inspection: Increased work of breathing may indicate pulmonary edema or pulmonary hemorrhage
- Auscultation: Crackles suggest pulmonary edema (fluid overload) or pulmonary hemorrhage (Goodpasture syndrome, granulomatosis with polyangiitis)
- Key point: Hemoptysis with hematuria is highly suggestive of pulmonary-renal syndrome — consider Goodpasture syndrome, granulomatosis with polyangiitis, or systemic lupus erythematosus
Abdominal Examination
Inspection
- Distension may indicate urinary retention with clot obstruction
- Visible flank mass in large renal tumors or polycystic kidneys
- Surgical scars from previous urological procedures
Palpation
- Kidneys: Normally not palpable except in thin patients; palpable kidney suggests hydronephrosis, tumor, or polycystic kidney disease; ballottement technique for deep palpation
- Bladder: Palpable suprapubic mass suggests urinary retention (clot retention or obstruction)
- Costovertebral angle tenderness: Suggests pyelonephritis, nephrolithiasis, or renal infarction
- Suprapubic tenderness: Suggests cystitis or bladder pathology
- Abdominal masses: May represent renal cell carcinoma, transitional cell carcinoma, or retroperitoneal lymphadenopathy
Percussion
- Costovertebral angle percussion: Tenderness (fist percussion test) suggests upper urinary tract pathology
- Suprapubic percussion: Dullness to percussion suggests distended bladder
Genitourinary Examination
Male Patients
| Structure | Technique | Findings and Significance |
|---|---|---|
| External genitalia | Inspect penis, urethral meatus, scrotum | Meatal lesions (caruncle, tumor); urethral discharge (urethritis); scrotal masses |
| Urethral meatus | Inspect and gently milk urethra | Blood at meatus suggests urethral injury; discharge suggests infection |
| Testes and epididymis | Palpate for masses, tenderness | Epididymal tenderness (epididymitis); testicular mass (metastatic renal cell carcinoma can spread to testes) |
| Varicocele | Palpate with patient standing | New left varicocele in older man suggests left renal vein obstruction (renal cell carcinoma or Nutcracker syndrome) |
| Digital rectal examination | Assess prostate size, consistency, nodules | Enlarged prostate (benign prostatic hyperplasia); hard nodule (prostate cancer); tender prostate (prostatitis) |
Female Patients
| Structure | Technique | Findings and Significance |
|---|---|---|
| External genitalia | Inspect vulva, urethral meatus, vaginal introitus | Urethral caruncle (benign cause of hematuria); atrophic changes; vaginal bleeding that may contaminate urine |
| Urethral meatus | Inspect for lesions, prolapse | Urethral caruncle (friable red mass at meatus); urethral prolapse |
| Vaginal examination | Speculum examination if indicated | Distinguish vaginal from urethral bleeding; cervical lesions; atrophic vaginitis |
| Bimanual examination | Assess uterus, adnexa, bladder | Pelvic masses that may compress urinary tract; bladder tenderness |
Skin and Extremities
Skin Findings
Palpable purpura: Immunoglobulin A vasculitis (Henoch-Schönlein purpura), cryoglobulinemic vasculitis
Malar rash: Systemic lupus erythematosus
Livedo reticularis: Atheroembolic disease, antiphospholipid syndrome
Splinter hemorrhages, Janeway lesions, Osler nodes: Infective endocarditis
Extremity Findings
Peripheral edema: Nephrotic syndrome, renal failure, heart failure
Arthritis: Systemic lupus erythematosus, reactive arthritis, immunoglobulin A vasculitis
Clubbing: Rare; may occur with renal cell carcinoma or chronic suppurative conditions
Lower extremity edema (unilateral): Consider deep vein thrombosis, especially with renal cell carcinoma (inferior vena cava involvement)
Expected Examination Findings by Etiology
| Condition | General Appearance | Abdominal and Genitourinary | Other Key Findings |
|---|---|---|---|
| Urinary tract infection | May appear uncomfortable; fever if pyelonephritis | Suprapubic tenderness (cystitis); costovertebral angle tenderness (pyelonephritis) | Usually otherwise normal |
| Nephrolithiasis | Restless, writhing in pain; diaphoretic | Costovertebral angle tenderness; no peritoneal signs | Unable to find comfortable position |
| Bladder cancer | May be entirely normal; cachexia if advanced | Usually normal; rarely palpable bladder mass | Often no abnormal findings |
| Renal cell carcinoma | May appear well or cachectic | Palpable flank mass (20%); left varicocele (2%) | Paraneoplastic signs: fever, hypertension, erythrocytosis |
| Benign prostatic hyperplasia | Normal appearance | Enlarged, smooth, firm prostate on digital rectal examination; distended bladder if retention | Usually normal |
| Glomerulonephritis | Edematous (facial, periorbital); pallor | Usually normal; no costovertebral angle tenderness | Hypertension; peripheral edema; signs of underlying disease |
| Polycystic kidney disease | May have hypertension | Bilaterally enlarged, palpable kidneys; hepatomegaly (liver cysts) | Hypertension; family history |
| Immunoglobulin A vasculitis | Palpable purpura on buttocks and lower extremities | Abdominal pain; may have gastrointestinal bleeding | Arthritis; scrotal swelling in males |
Important Teaching Point
Normal examination is common! Many causes of hematuria present with entirely normal physical examination findings. This is particularly true for:
- Early bladder cancer (often no palpable mass)
- Small renal cell carcinoma (discovered incidentally on imaging)
- Thin basement membrane nephropathy (isolated hematuria, no other findings)
- Immunoglobulin A nephropathy between flares
- Small kidney stones that have passed
A normal physical examination does NOT exclude significant pathology, including malignancy. The absence of findings should not deter appropriate investigation based on risk factors and clinical context.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Step-by-Step Approach to Hematuria Differential:
- Step 1: Confirm true hematuria — Rule out pseudohematuria (medications, foods, myoglobinuria, hemoglobinuria)
- Step 2: Determine glomerular versus non-glomerular source — Examine urine sediment for dysmorphic red blood cells, casts, and proteinuria
- Step 3: Classify by visibility — Gross hematuria has higher malignancy risk than microscopic hematuria
- Step 4: Risk stratify — Age, smoking history, and associated symptoms guide urgency of workup
Gross Hematuria (Visible Blood in Urine)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 60%) | Urinary tract infection | Dysuria, frequency, urgency, suprapubic pain; positive urine culture | Fever, flank pain (pyelonephritis) |
| Nephrolithiasis | Severe colicky flank pain radiating to groin; nausea; restlessness | Fever with obstruction (pyonephrosis) | |
| Benign prostatic hyperplasia (males) | Older male, voiding symptoms, enlarged prostate on examination | Must still exclude malignancy | |
| LESS COMMON (approximately 25%) | Bladder cancer | Painless gross hematuria; age over 40; smoking history; intermittent bleeding | Weight loss, pelvic pain (advanced disease) |
| Renal cell carcinoma | Flank pain, palpable mass; often incidental finding; paraneoplastic syndromes | New left varicocele, weight loss, bone pain | |
| Immunoglobulin A nephropathy | Gross hematuria during upper respiratory infection; young adult; tea-colored urine | Hypertension, rising creatinine | |
| Ureteral or renal pelvic tumor | Upper tract transitional cell carcinoma; similar risk factors to bladder cancer | Flank pain, hydronephrosis on imaging | |
| UNCOMMON BUT SERIOUS (approximately 15%) | Rapidly progressive glomerulonephritis | Acute kidney injury, hypertension, edema, oliguria; may have systemic symptoms | Rising creatinine over days; requires urgent nephrology referral |
| Renal infarction | Sudden flank pain, often with atrial fibrillation or recent cardiac procedure | Elevated lactate dehydrogenase, atrial fibrillation | |
| Arteriovenous malformation | Recurrent gross hematuria without other explanation; may have bruit | Severe hemorrhage requiring embolization | |
| Papillary necrosis | Diabetes, sickle cell disease, analgesic abuse; colicky pain from sloughed papilla | Bilateral disease, acute kidney injury |
Microscopic Hematuria (Non-visible)
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | No identifiable cause (idiopathic) | 40% to 50% | Complete workup negative; often resolves spontaneously; requires surveillance |
| Urinary tract infection | 15% to 20% | Pyuria, bacteriuria; resolves after treatment (recheck urinalysis) | |
| Benign prostatic hyperplasia | 10% to 15% | Older males, voiding symptoms, enlarged prostate | |
| Thin basement membrane nephropathy | 5% to 10% | Family history, isolated hematuria, normal renal function, excellent prognosis | |
| LESS COMMON | Nephrolithiasis | 5% to 10% | May be asymptomatic; history of stones; crystals on urinalysis |
| Immunoglobulin A nephropathy | 5% | May present with isolated microscopic hematuria; mild proteinuria | |
| Exercise-induced hematuria | Variable | Follows strenuous exercise; resolves within 72 hours of rest | |
| UNCOMMON BUT IMPORTANT | Bladder cancer | 2% to 5% | Higher risk in smokers, age over 40, occupational exposure |
| Renal cell carcinoma | Less than 1% | Often incidental finding on imaging; risk increases with age | |
| Alport syndrome | Rare | Family history of renal failure and deafness; progressive disease |
Differentiating Glomerular from Non-Glomerular Hematuria
Glomerular Causes
Clues: Dysmorphic red blood cells (greater than 80%), red blood cell casts, proteinuria greater than 500 mg per day, brown or tea-colored urine, absence of clots
- Immunoglobulin A nephropathy (most common)
- Thin basement membrane nephropathy
- Alport syndrome
- Post-infectious glomerulonephritis
- Lupus nephritis
- Anti-glomerular basement membrane disease (Goodpasture syndrome)
- ANCA-associated vasculitis
- Membranoproliferative glomerulonephritis
- Focal segmental glomerulosclerosis
Non-Glomerular Causes
Clues: Isomorphic red blood cells, no red blood cell casts, minimal proteinuria (less than 500 mg per day), red or pink urine, clots may be present
- Urinary tract infection
- Nephrolithiasis
- Bladder cancer
- Renal cell carcinoma
- Benign prostatic hyperplasia
- Urothelial carcinoma (ureter, renal pelvis)
- Polycystic kidney disease
- Trauma
- Urethral stricture or caruncle
- Radiation cystitis
Anatomical Approach to Differential Diagnosis
Kidney (Parenchymal)
Glomerulonephritis (all types)
Renal cell carcinoma
Polycystic kidney disease
Interstitial nephritis
Papillary necrosis
Renal infarction
Arteriovenous malformation
Renal vein thrombosis
Renal Pelvis and Ureter
Nephrolithiasis
Transitional cell carcinoma
Pyelonephritis
Stricture
Ureteropelvic junction obstruction
Tuberculosis
Schistosomiasis
Bladder
Bladder cancer (transitional cell)
Cystitis (infectious, radiation, hemorrhagic)
Bladder stones
Bladder diverticulum
Interstitial cystitis
Schistosomiasis
Endometriosis
Prostate and Urethra
Benign prostatic hyperplasia
Prostate cancer
Prostatitis
Urethritis
Urethral stricture
Urethral caruncle
Urethral trauma
Drug-Induced Hematuria
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Anticoagulants (warfarin, direct oral anticoagulants) | Unmask underlying pathology; do not cause hematuria de novo | Any pattern; underlying lesion found in up to 25% | Full workup required; do not attribute to anticoagulation alone |
| Antiplatelet agents (aspirin, clopidogrel) | Unmask underlying pathology; impair platelet function | Similar to anticoagulants | Full workup required |
| Cyclophosphamide | Acrolein metabolite causes hemorrhagic cystitis | Gross hematuria; may be delayed onset; dose-related | Prevention with mesna; hydration; may require cystoscopy |
| Ifosfamide | Same mechanism as cyclophosphamide | Hemorrhagic cystitis | Always co-administer mesna |
| Nonsteroidal anti-inflammatory drugs | Acute interstitial nephritis; papillary necrosis with chronic use | May have eosinophiluria; chronic use causes analgesic nephropathy | Discontinue offending agent; renal function monitoring |
| Penicillins, cephalosporins, sulfonamides | Drug-induced acute interstitial nephritis (hypersensitivity) | Fever, rash, eosinophilia; eosinophiluria; elevated creatinine | Discontinue drug; may require steroids |
| Rifampin | Acute interstitial nephritis; also causes pseudohematuria (red-orange urine) | Distinguish true hematuria from discoloration with microscopy | Check urine sediment for red blood cells |
| Radiation therapy (pelvic) | Radiation cystitis; mucosal telangiectasias; may occur years after treatment | Gross hematuria; may be recurrent; bladder capacity reduced | Cystoscopy; fulguration; hyperbaric oxygen in refractory cases |
| Ticlodipine | Thrombotic thrombocytopenic purpura with microangiopathic hemolytic anemia | Thrombocytopenia, schistocytes, elevated lactate dehydrogenase | Emergency plasma exchange |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Painless gross hematuria in smoker over 40 | Bladder cancer | Urgent cystoscopy and computed tomography urography |
| Colicky flank pain with hematuria | Nephrolithiasis | Computed tomography without contrast (stone protocol) |
| Dysuria, frequency with hematuria | Urinary tract infection | Urinalysis and urine culture; recheck after treatment |
| Tea-colored urine during upper respiratory infection | Immunoglobulin A nephropathy | Urine sediment, protein quantification, nephrology referral |
| Hematuria with red blood cell casts | Glomerulonephritis | Urgent nephrology referral; serologic workup |
| Hematuria with hemoptysis | Pulmonary-renal syndrome (Goodpasture, granulomatosis with polyangiitis) | Emergency evaluation; anti-glomerular basement membrane antibody, ANCA |
| Gross hematuria 1 to 2 weeks after pharyngitis | Post-streptococcal glomerulonephritis | Complement levels (low C3), anti-streptolysin O titer |
| New left varicocele in older man | Left renal vein obstruction (renal cell carcinoma) | Computed tomography of abdomen with contrast |
| Hematuria with palpable purpura | Immunoglobulin A vasculitis or other systemic vasculitis | Skin biopsy, renal function, nephrology referral |
| Family history of hematuria and deafness | Alport syndrome | Ophthalmology examination, audiometry, genetic testing |
| Hematuria after marathon or intense exercise | Exercise-induced hematuria | Repeat urinalysis after 72 hours rest; if persistent, full workup |
| Hematuria in patient on anticoagulation | Underlying pathology unmasked by anticoagulation | Full workup required; do not dismiss as anticoagulation effect |
Age-Based Malignancy Risk
The risk of urological malignancy increases significantly with age, particularly in the presence of gross hematuria:
- Under 40 years: Malignancy uncommon (less than 1%); more likely infection, stones, glomerular disease
- 40 to 59 years: Intermediate risk (5% to 10%); full workup recommended
- 60 years and older: Highest risk (15% to 25% with gross hematuria); cystoscopy and imaging essential
Other high-risk features: Male sex, smoking history, occupational exposures, prior pelvic radiation, cyclophosphamide exposure, chronic indwelling catheter
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Hematuria
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Urinalysis with microscopy | Confirm hematuria; characterize sediment; identify infection | Red blood cell count and morphology; white blood cells; bacteria; casts; crystals; protein | Fresh specimen essential; dysmorphic red blood cells greater than 80% suggest glomerular source; red blood cell casts are pathognomonic for glomerular disease |
| Urine culture | Identify urinary tract infection | Bacterial growth greater than 100,000 colony-forming units per mL | If positive, treat and repeat urinalysis 6 weeks later; persistent hematuria requires further workup |
| Serum creatinine and estimated glomerular filtration rate | Assess renal function | Elevated creatinine suggests renal parenchymal disease or obstruction | Baseline for monitoring; affects choice of contrast imaging |
| Complete blood count | Assess for anemia, infection, hematologic abnormalities | Anemia (chronic blood loss); leukocytosis (infection); thrombocytopenia (microangiopathy) | Anemia suggests significant or chronic bleeding |
| Coagulation studies (if indicated) | Identify coagulopathy | Elevated prothrombin time or international normalized ratio; elevated partial thromboplastin time | Check in patients on anticoagulants or with bleeding history; coagulopathy unmasks but does not cause hematuria |
| Urine protein quantification | Assess for glomerular disease | Protein-to-creatinine ratio greater than 0.5 g/g or 24-hour protein greater than 500 mg suggests glomerular pathology | Significant proteinuria with hematuria strongly suggests glomerular source |
Interpreting Urine Microscopy: The Key Decision Point
Urine sediment examination is critical for determining the source of hematuria:
Glomerular Source Indicators:
- Dysmorphic red blood cells greater than 80%
- Acanthocytes greater than 5% (highly specific)
- Red blood cell casts (pathognomonic)
- Proteinuria greater than 500 mg per day
Non-Glomerular Source Indicators:
- Isomorphic (normal) red blood cells
- Absence of casts
- Minimal or no proteinuria
- Blood clots may be present
Imaging Studies
| Imaging Modality | When to Use | What It Shows | Limitations |
|---|---|---|---|
| Computed tomography urography (with and without contrast) | First-line imaging for suspected non-glomerular hematuria; high-risk patients | Renal masses, urothelial tumors, stones, hydronephrosis, bladder masses | Contrast contraindicated if estimated glomerular filtration rate less than 30; radiation exposure; may miss small bladder tumors |
| Non-contrast computed tomography (stone protocol) | Suspected nephrolithiasis; acute flank pain | Stones (sensitivity greater than 95%), hydronephrosis, perinephric stranding | Cannot evaluate for soft tissue masses; does not assess collecting system |
| Renal ultrasound | Initial imaging in low-risk patients; pregnant patients; chronic kidney disease (avoid contrast) | Hydronephrosis, large renal masses, cysts, bladder volume | Limited for small masses, ureteral pathology, and bladder tumors; operator dependent |
| Magnetic resonance urography | Contrast allergy; pregnancy (without gadolinium); young patients (avoid radiation) | Renal masses, collecting system abnormalities | Less available; longer examination time; cannot detect stones |
| Intravenous pyelography | Rarely used; largely replaced by computed tomography urography | Collecting system anatomy, filling defects | Lower sensitivity than computed tomography; requires contrast |
Cystoscopy
Indications for Cystoscopy:
- All patients with gross hematuria (after urinary tract infection excluded)
- Microscopic hematuria with high-risk features (age over 40, smoking, occupational exposures)
- Microscopic hematuria with abnormal imaging
- Persistent microscopic hematuria after negative initial workup
- Irritative voiding symptoms without infection
What cystoscopy evaluates: Bladder mucosa, ureteral orifices (lateralizing hematuria), prostatic urethra, bladder neck
Important: Computed tomography urography cannot adequately evaluate the bladder mucosa for small or flat tumors; cystoscopy remains essential
Targeted Investigations by Suspected Etiology
If Suspecting Glomerular Disease
First-Line Tests
- Urine protein-to-creatinine ratio: Greater than 0.5 g/g suggests glomerular disease
- Serum creatinine and estimated glomerular filtration rate: Assess renal function
- Complement levels (C3, C4): Low in post-infectious glomerulonephritis, lupus nephritis, membranoproliferative glomerulonephritis
- Antinuclear antibody: Screening for systemic lupus erythematosus
Second-Line Tests
- Anti-double-stranded DNA antibody: Specific for lupus nephritis
- Anti-neutrophil cytoplasmic antibody (ANCA): Granulomatosis with polyangiitis, microscopic polyangiitis
- Anti-glomerular basement membrane antibody: Goodpasture syndrome
- Hepatitis B and C serologies: Associated with membranous nephropathy, cryoglobulinemia
- Serum and urine protein electrophoresis: If suspecting myeloma or amyloidosis
- Renal biopsy: Gold standard for diagnosis; indicated when diagnosis unclear or to guide treatment
If Suspecting Urological Malignancy
First-Line Tests
- Computed tomography urography: Evaluate kidneys, ureters, bladder
- Cystoscopy: Direct visualization of bladder; biopsy of suspicious lesions
- Urine cytology: Sensitivity 40% to 60% for high-grade tumors; low sensitivity for low-grade tumors
Second-Line Tests
- Ureteroscopy: Evaluate upper tract if filling defect on imaging
- Fluorescence in situ hybridization (UroVysion): Urine-based test; higher sensitivity than cytology
- Blue light cystoscopy: Enhanced detection of carcinoma in situ
- Computed tomography of chest, abdomen, pelvis: Staging if malignancy confirmed
If Suspecting Nephrolithiasis
First-Line Tests
- Non-contrast computed tomography: Gold standard; sensitivity greater than 95% for stones
- Urinalysis: Hematuria (85% sensitivity), crystals, pH (uric acid stones form in acidic urine)
- Serum creatinine: Assess renal function, especially with obstruction
Metabolic Workup (Recurrent Stones)
- Serum calcium, phosphorus, uric acid: Screen for metabolic abnormalities
- Parathyroid hormone: If hypercalcemia present
- 24-hour urine collection: Calcium, oxalate, citrate, uric acid, sodium, volume
- Stone analysis: Essential when stone is recovered
Understanding Urine Cytology and Tumor Markers
| Test | Sensitivity | Specificity | Best Use |
|---|---|---|---|
| Urine cytology | 40% to 60% overall; higher for high-grade tumors (80% to 90%) | Greater than 90% | Detecting high-grade urothelial carcinoma and carcinoma in situ; surveillance after bladder cancer diagnosis |
| Fluorescence in situ hybridization (UroVysion) | 70% to 80% | 70% to 80% | Equivocal cytology; surveillance; detecting recurrence |
| Nuclear matrix protein 22 | 50% to 70% | 70% to 80% | Point-of-care testing; false positives with infection, inflammation, stones |
| Bladder tumor antigen | 50% to 70% | 60% to 75% | Limited clinical utility due to false positives |
Practical Point: Urine Cytology Limitations
Urine cytology has excellent specificity but limited sensitivity, especially for low-grade papillary tumors. A negative cytology does NOT rule out bladder cancer. Cytology is most useful for:
- Detecting high-grade urothelial carcinoma and carcinoma in situ
- Surveillance after bladder cancer treatment
- Evaluating upper tract when ureteroscopy not feasible
Always perform cystoscopy in high-risk patients regardless of cytology results.
Risk-Stratified Investigation Approach
| Risk Category | Criteria | Recommended Workup |
|---|---|---|
| Low Risk | Age less than 40; never smoker; 3 to 10 red blood cells per high-power field on single urinalysis; no other risk factors | Repeat urinalysis in 6 months; if persistent, renal ultrasound; shared decision-making regarding cystoscopy |
| Intermediate Risk | Age 40 to 59; 10 to 25 pack-year smoking history; 11 to 25 red blood cells per high-power field; persistent microscopic hematuria | Renal ultrasound or computed tomography urography; cystoscopy recommended |
| High Risk | Age 60 or older; greater than 25 red blood cells per high-power field; gross hematuria; greater than 30 pack-year smoking history; prior pelvic radiation or cyclophosphamide | Computed tomography urography AND cystoscopy mandatory |
When Initial Workup Is Negative
Surveillance Protocol for Negative Initial Evaluation
If computed tomography urography, cystoscopy, and urine cytology are all negative:
- Low-risk patients: Discharge with patient education; repeat urinalysis annually for 2 years
- Intermediate-risk patients: Repeat urinalysis at 6 months and 12 months; consider repeat cystoscopy at 1 year
- High-risk patients: Urinalysis and cytology every 6 months for 2 years; consider repeat imaging and cystoscopy if hematuria persists
- All patients: Immediate re-evaluation if gross hematuria develops, symptoms change, or hematuria worsens
Nephrology referral: Consider if hematuria persists with proteinuria, elevated creatinine, dysmorphic red blood cells, or red blood cell casts
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Hemodynamic instability with gross hematuria | EMERGENT | Resuscitate; large-bore intravenous access; type and crossmatch; urology consult; consider intensive care unit |
| Urinary retention from clot obstruction | EMERGENT | Three-way catheter placement; continuous bladder irrigation; urology consult |
| Hematuria with acute kidney injury (rising creatinine) | EMERGENT | Urgent nephrology referral; consider rapidly progressive glomerulonephritis; serologic workup |
| Hematuria with hemoptysis (pulmonary-renal syndrome) | EMERGENT | Immediate nephrology and pulmonology consultation; anti-glomerular basement membrane antibody and ANCA; prepare for possible plasmapheresis |
| Gross hematuria with fever and flank pain | URGENT | Evaluate for pyelonephritis versus infected obstructed kidney; imaging; broad-spectrum antibiotics if septic |
| Painless gross hematuria in patient over 40 | URGENT | High suspicion for malignancy; expedited computed tomography urography and cystoscopy within 2 weeks |
| Gross hematuria with severe colicky flank pain | URGENT | Likely nephrolithiasis; non-contrast computed tomography; pain control; assess for obstruction and infection |
| Microscopic hematuria, asymptomatic, low risk | ROUTINE | Confirm on repeat urinalysis; risk stratify; outpatient workup based on risk category |
| Hematuria with dysuria and frequency (likely urinary tract infection) | ROUTINE | Urine culture; treat infection; repeat urinalysis 6 weeks after treatment to confirm resolution |
Step 2: Classify the Hematuria
Gross Hematuria
Action: Always requires full urological workup
Proceed to Algorithm A
Microscopic Hematuria (Glomerular Features)
Action: Nephrology evaluation
Proceed to Algorithm B
Microscopic Hematuria (Non-Glomerular)
Action: Risk-stratified urological workup
Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Gross Hematuria
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Painless gross hematuria, age over 40, smoking history | Bladder cancer until proven otherwise | Computed tomography urography plus cystoscopy within 2 weeks |
| Gross hematuria with severe colicky flank pain | Nephrolithiasis | Non-contrast computed tomography; pain management; urology referral if stone greater than 6 mm or obstruction |
| Gross hematuria with dysuria, frequency, fever | Urinary tract infection or pyelonephritis | Urine culture; antibiotics; repeat urinalysis 6 weeks after treatment; if hematuria persists, full workup |
| Tea-colored urine during or immediately after upper respiratory infection | Immunoglobulin A nephropathy | Check urine sediment (dysmorphic red blood cells, casts); protein quantification; nephrology referral |
| Gross hematuria with edema, hypertension, oliguria | Acute glomerulonephritis | Urgent nephrology referral; serum creatinine; complement levels; consider renal biopsy |
| Gross hematuria following trauma | Renal or bladder injury | Computed tomography with contrast; assess for extravasation; urology and trauma surgery consultation |
| Gross hematuria after vigorous exercise | Exercise-induced hematuria | Rest; repeat urinalysis in 72 hours; if persistent, full workup to exclude underlying pathology |
| Older male with gross hematuria and voiding symptoms | Benign prostatic hyperplasia (but must exclude malignancy) | Digital rectal examination; prostate-specific antigen; computed tomography urography plus cystoscopy |
Algorithm B: Microscopic Hematuria with Glomerular Features
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Dysmorphic red blood cells, red blood cell casts, proteinuria greater than 500 mg per day | Glomerulonephritis (type to be determined) | Nephrology referral; serologic workup (complement, antinuclear antibody, ANCA, anti-glomerular basement membrane); likely renal biopsy |
| Isolated microscopic hematuria, family history of hematuria, normal renal function | Thin basement membrane nephropathy | Reassurance; annual monitoring of blood pressure, creatinine, protein; genetic testing if Alport suspected |
| Microscopic hematuria with progressive renal insufficiency and hearing loss | Alport syndrome | Ophthalmology examination; audiometry; genetic testing; nephrology follow-up |
| Microscopic hematuria with rash, arthritis, abdominal pain | Immunoglobulin A vasculitis (Henoch-Schönlein purpura) or systemic vasculitis | Skin biopsy; renal function monitoring; nephrology and rheumatology referral |
| Microscopic hematuria 1 to 2 weeks after streptococcal pharyngitis | Post-streptococcal glomerulonephritis | Complement levels (low C3); anti-streptolysin O titer; supportive care; usually self-limited |
Algorithm C: Microscopic Hematuria (Non-Glomerular) — Risk-Based Approach
| Risk Level | Patient Profile | Action |
|---|---|---|
| Low Risk | Age less than 40; never smoker; 3 to 10 red blood cells per high-power field; no other risk factors; female with possible urinary tract infection | Repeat urinalysis in 6 months; if persistent, renal ultrasound; shared decision-making for cystoscopy; annual urinalysis for 2 years if workup negative |
| Intermediate Risk | Age 40 to 59; or 10 to 25 pack-year smoking; or 11 to 25 red blood cells per high-power field; or persistent microscopic hematuria | Renal ultrasound or computed tomography urography; cystoscopy recommended; urine cytology optional |
| High Risk | Age 60 or older; or greater than 30 pack-year smoking; or greater than 25 red blood cells per high-power field; or prior gross hematuria | Computed tomography urography AND cystoscopy mandatory; urine cytology |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient on anticoagulation with new hematuria | Do NOT attribute to anticoagulation; check international normalized ratio or anticoagulant levels | Full workup as per risk category; underlying pathology found in up to 25% |
| Hematuria clears after treating urinary tract infection | Document resolution with repeat urinalysis at 6 weeks | If hematuria persists after treatment, proceed with full workup |
| Computed tomography urography and cystoscopy both negative | Reassure patient; stratify by risk level | Surveillance: repeat urinalysis at 6 and 12 months; consider nephrology if glomerular features present |
| Young patient (under 35) with isolated microscopic hematuria | Check for dysmorphic red blood cells and proteinuria | If glomerular features: nephrology referral; if non-glomerular: renal ultrasound; consider thin basement membrane nephropathy |
| Recurrent gross hematuria with negative workup | Review all prior imaging and cystoscopy findings | Consider: loin pain hematuria syndrome, nutcracker syndrome, arteriovenous malformation; angiography may be needed |
| Microscopic hematuria in pregnant patient | Urinalysis and culture; renal ultrasound (no radiation) | Defer computed tomography and cystoscopy until postpartum unless high-risk features |
| Dipstick positive but no red blood cells on microscopy | Consider hemoglobinuria or myoglobinuria | Check creatine kinase (rhabdomyolysis); lactate dehydrogenase and haptoglobin (hemolysis); not true hematuria |
| Patient refuses cystoscopy | Document discussion of risks; perform computed tomography urography and urine cytology | Close surveillance; re-offer cystoscopy; explain that small bladder tumors may be missed on imaging |
| Hematuria with recent urological procedure | Likely post-procedural; assess severity and duration | If mild and improving, observe; if severe or prolonged, contact proceduralist; consider clot retention |
Troubleshooting Persistent or Unexplained Hematuria
When Standard Workup Is Negative — Ask These Questions
- Was the urinalysis technique adequate? (fresh specimen, clean catch, mid-stream)
- Was urinary tract infection properly treated and resolved?
- Were dysmorphic red blood cells and casts specifically looked for?
- Was computed tomography urography performed with proper protocol (non-contrast plus nephrographic plus excretory phases)?
- Was cystoscopy performed by experienced urologist with adequate bladder distension?
- Was urine cytology obtained and interpreted by experienced cytopathologist?
- Are there glomerular features that warrant nephrology evaluation?
- Could this be a vascular cause (arteriovenous malformation, nutcracker syndrome)?
Special Populations
Pregnant Patients
- Avoid ionizing radiation (no computed tomography)
- Renal ultrasound is first-line imaging
- Magnetic resonance imaging without gadolinium if further imaging needed
- Defer cystoscopy until postpartum unless high-risk features
- Urinary tract infection more common; treat promptly
Chronic Kidney Disease Patients
- Avoid iodinated contrast if estimated glomerular filtration rate less than 30
- Non-contrast computed tomography or magnetic resonance urography preferred
- Higher baseline risk of renal cell carcinoma in dialysis patients
- Acquired cystic kidney disease increases malignancy risk
- Coordinate with nephrology for workup planning
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Painless gross hematuria is bladder cancer until proven otherwise: This classic presentation, especially in smokers over age 40, demands urgent cystoscopy and computed tomography urography. Do not delay evaluation even if hematuria is intermittent or resolves spontaneously.
Anticoagulation unmasks pathology; it does not cause hematuria: Patients on warfarin, direct oral anticoagulants, or antiplatelet agents who develop hematuria require full evaluation. Up to 25% have significant underlying pathology including malignancy.
Red blood cell casts are pathognomonic for glomerular disease: Finding red blood cell casts on urine microscopy immediately identifies a glomerular source and directs evaluation toward nephrology rather than urology.
Synpharyngitic hematuria points to immunoglobulin A nephropathy: Gross hematuria occurring during (not 1 to 2 weeks after) an upper respiratory infection is characteristic of immunoglobulin A nephropathy. Post-streptococcal glomerulonephritis occurs 1 to 2 weeks after infection.
Acanthocytes greater than 5% are highly specific for glomerular bleeding: These ring-shaped red blood cells with membrane protrusions are more specific than general dysmorphic red blood cells for identifying glomerular pathology.
New left-sided varicocele in an older man suggests renal vein obstruction: A left varicocele that does not decompress when supine, especially with new onset in an older patient, may indicate left renal vein compression by a renal tumor.
Computed tomography urography cannot adequately evaluate the bladder: Even with excellent imaging, small or flat bladder tumors (especially carcinoma in situ) may be missed. Cystoscopy remains essential for complete evaluation of the lower urinary tract.
Hematuria with hemoptysis is a medical emergency: The combination suggests pulmonary-renal syndrome (Goodpasture syndrome or ANCA-associated vasculitis). Immediate evaluation and treatment can prevent irreversible organ damage.
Critical Pitfalls to Avoid
Attributing hematuria to anticoagulation without workup: This is one of the most dangerous errors. Anticoagulants do not cause hematuria de novo; they unmask underlying lesions. Significant pathology is found in up to 25% of anticoagulated patients with hematuria.
Stopping workup when hematuria resolves spontaneously: Bladder cancer classically causes intermittent hematuria. A single negative urinalysis after an episode of gross hematuria does not exclude malignancy. Complete the full indicated workup.
Assuming microscopic hematuria is benign in older patients: While malignancy is less common with microscopic than gross hematuria, the risk is not negligible, especially in patients over 60 with risk factors. Risk-stratify and investigate appropriately.
Relying on urine cytology to rule out bladder cancer: Cytology has poor sensitivity (40% to 60%) for low-grade tumors. A negative cytology does not exclude bladder cancer. Cystoscopy is required for adequate evaluation.
Missing glomerular hematuria by not examining urine sediment: Skipping microscopy and relying only on dipstick results misses the critical distinction between glomerular and non-glomerular sources. Always examine fresh urine sediment for dysmorphic red blood cells and casts.
Forgetting to recheck urinalysis after treating urinary tract infection: Hematuria should resolve after successful treatment of urinary tract infection. Persistent hematuria despite negative cultures requires full evaluation to exclude other pathology.
Dismissing hematuria in young patients: While malignancy is rare in patients under 40, glomerular diseases (immunoglobulin A nephropathy, thin basement membrane nephropathy, Alport syndrome) commonly present in younger patients and require appropriate evaluation.
Using ultrasound alone for high-risk patients: Renal ultrasound has limited sensitivity for small masses and cannot evaluate the ureters or bladder mucosa adequately. High-risk patients require computed tomography urography and cystoscopy.
Key Takeaways
- Confirm true hematuria with microscopy before extensive workup; rule out pseudohematuria from medications, foods, or pigments (hemoglobin, myoglobin)
- The first decision point is glomerular versus non-glomerular: look for dysmorphic red blood cells greater than 80%, red blood cell casts, and significant proteinuria to identify glomerular sources
- Gross hematuria carries higher malignancy risk than microscopic hematuria and always warrants complete urological evaluation with computed tomography urography and cystoscopy
- Painless gross hematuria in patients over 40, especially smokers, is bladder cancer until proven otherwise — pursue urgent evaluation
- Never attribute hematuria to anticoagulation without investigation; up to 25% of anticoagulated patients with hematuria have significant underlying pathology
- Risk stratify microscopic hematuria based on age, smoking history, and red blood cell count to guide intensity of workup
- Computed tomography urography evaluates the upper tracts but cannot adequately assess the bladder mucosa; cystoscopy remains essential for complete lower tract evaluation
- Hematuria with hemoptysis is a medical emergency suggesting pulmonary-renal syndrome requiring immediate nephrology consultation
- If initial workup is negative, establish a surveillance protocol based on risk category; re-evaluate promptly if hematuria worsens or becomes gross
- Consider nephrology referral when glomerular features are present, renal function is declining, or proteinuria accompanies hematuria
Quick Reference Algorithm
Systematic Approach to Hematuria:
- Confirm true hematuria: Microscopy showing ≥3 red blood cells per high-power field; rule out pseudohematuria
- Assess urgency: Hemodynamic instability, clot retention, acute kidney injury, or pulmonary-renal syndrome require emergent evaluation
- Determine source: Examine urine sediment for dysmorphic red blood cells, casts, and proteinuria to distinguish glomerular from non-glomerular origin
- If glomerular: Nephrology referral; serologic workup (complement, antinuclear antibody, ANCA, anti-glomerular basement membrane); consider renal biopsy
- If non-glomerular: Risk stratify based on age, smoking, and red blood cell count; pursue imaging (computed tomography urography) and cystoscopy based on risk level
- Treat underlying cause: Infection, stones, malignancy, or glomerular disease as identified
- Establish surveillance: If initial workup negative, follow with periodic urinalysis based on risk; re-evaluate promptly for new symptoms or worsening hematuria